Biotage AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 449 million compared to SEK 401 million a year ago. Net income was SEK 38 million compared to SEK 65 million a year ago. Basic earnings per share from continuing operations was SEK 0.48 compared to SEK 0.48 a year ago. Diluted earnings per share from continuing operations was SEK 0.48 compared to SEK 0.48 a year ago.
For the nine months, sales was SEK 1,219 million compared to SEK 1,182 million a year ago. Net income was SEK 115 million compared to SEK 194 million a year ago. Basic earnings per share from continuing operations was SEK 1.6 compared to SEK 2.94 a year ago. Diluted earnings per share from continuing operations was SEK 1.6 compared to SEK 2.93 a year ago.